Early graft failure after heart transplant: risk factors and implications for improved donor-recipient matching

Cristiano Amarelli1, Luca Salvatore De Santo, Claudio Marra

  • 1Department of Cardiovascular Surgery and Transplants, Monaldi Hospital, Naples, Italy.

Insights

Early graft failure (EGF) after heart transplantation (HT) is a serious complication with poor outcomes. Identifying risk factors like donor-recipient mismatch is crucial for prevention.

Area of Science:

  • Cardiology
  • Transplantation Immunology

Background:

  • Early graft failure (EGF) remains a significant challenge after heart transplantation (HT).
  • Current therapeutic options for EGF are limited, and the prognosis is generally poor.
  • Understanding risk factors is essential for improving patient outcomes.

Purpose of the Study:

  • To identify risk factors associated with early graft failure (EGF) after heart transplantation (HT).
  • To evaluate the clinical impact and outcomes of EGF.
  • To stratify patients based on EGF risk and compare outcomes.

Main Methods:

  • Retrospective analysis of 317 consecutive heart transplants (HT) performed between January 1999 and December 2008.
  • Bivariate and multivariable discriminant analyses to identify significant risk factors for EGF.
  • Propensity score derivation to stratify patients into low, intermediate, and high-risk groups for EGF.

Main Results:

  • Early graft failure (EGF) occurred in 10.1% of patients, with rates of 2.9%, 3.8%, and 23.6% in the low, intermediate, and high-risk groups, respectively.
  • EGF-related mortality was 56.3% overall, with higher rates in the high-risk group (48-100%).
  • Key predictors of EGF in the highest-risk group included redo procedures, valvular cardiomyopathy, recipient status, donor-recipient weight mismatch, donor support, ischemic time, and troponin I levels.

Conclusions:

  • Several donor and recipient characteristics significantly predict early graft failure (EGF) after heart transplantation (HT).
  • These risk factors, while not easily modifiable, synergistically contribute to EGF occurrence.
  • Optimizing donor-recipient matching is a critical strategy for preventing EGF and improving long-term transplant success.

Related Concept Videos

Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
Tissue Transplantation01:24

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living donor...
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...